Targeting specific cells in the brain with nanomedicines for CNS therapies.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Journal of Controlled Release

• Publication date

  2016-10-28

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1016/j.jconrel.2015.12.013PMID 26686078PMCID PMC4903089
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serveur Académique Lausannois SERVAL serval.unil.ch

  2017cited by this paper
• Targeting microglia for the treatment of Alzheimer's Disease

  2016cited by this paper
• Multifunctionalized CMCht/PAMAM Dendrimer Nanoparticles Modulate the Cellular Uptake by Astrocytes and Oligodendrocytes in Primary Cultures of Glial Cells.

  2016cited by this paper
• Photosensitivity of neurons enabled by cell-targeted gold nanoparticles.

  2015cited by this paper
• Fluorescent Phosphorus Dendrimer as a Spectral Nanosensor for Macrophage Polarization and Fate Tracking in Spinal Cord Injury.

  2015cited by this paper
• Localized RNAi therapeutics of chemoresistant grade IV glioma using hyaluronan-grafted lipid-based nanoparticles.

  2015cited by this paper
• Dendritic Polyglycerol Sulfate Inhibits Microglial Activation and Reduces Hippocampal CA1 Dendritic Spine Morphology Deficits.

  2015cited by this paper
• Systemic dendrimer-drug treatment of ischemia-induced neonatal white matter injury.

  2015cited by this paper
• Macrophage Targeted Theranostics as Personalized Nanomedicine Strategies for Inflammatory Diseases

  2015cited by this paper
• Selective neuronal targeting, protection and signaling network analysis via dopamine-mediated mesoporous silica nanoparticles

  2015cited by this paper
• Systemically Administered Brain-Targeted Nanoparticles Transport Peptides across the Blood—Brain Barrier and Provide Neuroprotection

  2015cited by this paper
• Nanocarrier-mediated inhibition of macrophage migration inhibitory factor attenuates secondary injury after spinal cord injury.

  2015influential reference
• Uniform brain tumor distribution and tumor associated macrophage targeting of systemically administered dendrimers.

  2015cited by this paper
• Metabolic Reprograming of Mononuclear Phagocytes in Progressive Multiple Sclerosis

  2015cited by this paper
• Wireless magnetothermal deep brain stimulation

  2015cited by this paper
• Exosomes as drug delivery vehicles for Parkinson's disease therapy.

  2015cited by this paper
• Functionalized iron oxide nanoparticles for controlling the movement of immune cells.

  2015cited by this paper
• Nanoparticle-loaded macrophage-mediated photothermal therapy: potential for glioma treatment

  2015cited by this paper
• Polymeric Nanoparticles for Nonviral Gene Therapy Extend Brain Tumor Survival in Vivo

  2015cited by this paper
• Targeting microglia for the treatment of Alzheimer’s disease

  2015cited by this paper
• Dendrimer Brain Uptake and Targeted Therapy for Brain Injury in a Large Animal Model of Hypothermic Circulatory Arrest

  2014cited by this paper
• Breaching the blood-brain barrier for drug delivery.

  2014cited by this paper
• Synergistic dual-ligand doxorubicin liposomes improve targeting and therapeutic efficacy of brain glioma in animals.

  2014cited by this paper
• Tumor-associated macrophages: from mechanisms to therapy.

  2014cited by this paper
• Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties.

  2014influential reference
• Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting.

  2014cited by this paper
• Biodegradable Polymeric Nanoparticles Show High Efficacy and Specificity at DNA Delivery to Human Glioblastoma in Vitro and in Vivo

  2014cited by this paper
• Transport of nanoparticles through the blood-brain barrier for imaging and therapeutic applications.

  2014cited by this paper
• Neuroinflammation and M2 microglia: the good, the bad, and the inflamed

  2014influential reference
• The role of autophagy in the neurotoxicity of cationic PAMAM dendrimers.

  2014cited by this paper
• Tumor-targeting dual peptides-modified cationic liposomes for delivery of siRNA and docetaxel to gliomas.

  2014influential reference
• Drug delivery to the central nervous system by polymeric nanoparticles: what do we know?

  2014cited by this paper
• Effects of PAMAM dendrimers in the mouse brain after a single intranasal instillation.

  2014cited by this paper
• Increased brain penetration and potency of a therapeutic antibody using a monovalent molecular shuttle.

  2014cited by this paper
• Macrophages offer a paradigm switch for CNS delivery of therapeutic proteins.

  2014cited by this paper
• Polymeric nanoparticle system to target activated microglia/macrophages in spinal cord injury.

  2014influential reference
• Phase I Study of GRN1005 in Recurrent Malignant Glioma

  2013influential reference
• Handling of Iron Oxide and Silver Nanoparticles by Astrocytes

  2013cited by this paper
• Optimization of Tet1 ligand density in HPMA-co-oligolysine copolymers for targeted neuronal gene delivery.

  2013influential reference
• Lipid Nanoparticle Delivery of siRNA to Silence Neuronal Gene Expression in the Brain

  2013cited by this paper
• Inflammation and neurovascular changes in amyotrophic lateral sclerosis.

  2013cited by this paper
• Iron oxide nanoparticles suppress the production of IL-1beta via the secretory lysosomal pathway in murine microglial cells

  2013cited by this paper
• Addressing Safety Liabilities of TfR Bispecific Antibodies That Cross the Blood-Brain Barrier

  2013cited by this paper
• Selective nanovector mediated treatment of activated proinflammatory microglia/macrophages in spinal cord injury.

  2013influential reference
• The permeability of puerarin loaded poly(butylcyanoacrylate) nanoparticles coated with polysorbate 80 on the blood-brain barrier and its protective effect against cerebral ischemia/reperfusion injury.

  2013cited by this paper
• Regulation of Microglial Proliferation during Chronic Neurodegeneration

  2013cited by this paper
• Brain-targeting delivery for RNAi neuroprotection against cerebral ischemia reperfusion injury.

  2013cited by this paper
• Glioma targeting and blood-brain barrier penetration by dual-targeting doxorubincin liposomes.

  2013influential reference
• Neural and Immune Mechanisms in the Pathogenesis of Parkinson’s Disease

  2013cited by this paper
• Review: Activation patterns of microglia and their identification in the human brain

  2013cited by this paper
• Blood-brain barrier molecular trojan horse enables imaging of brain uptake of radioiodinated recombinant protein in the rhesus monkey.

  2013cited by this paper
• Reduction of nanoparticle avidity enhances the selectivity of vascular targeting and PET detection of pulmonary inflammation.

  2013cited by this paper
• Nanomedicine in cerebral palsy

  2013cited by this paper
• Detection of vascular cell adhesion molecule-1 expression with USPIO-enhanced molecular MRI in a mouse model of cerebral ischemia.

  2013cited by this paper
• Role of Oxidative Stress in Parkinson's Disease

  2013cited by this paper
• Microglia and Macrophages in Malignant Gliomas: Recent Discoveries and Implications for Promising Therapies

  2013cited by this paper
• Microglia response and in vivo therapeutic potential of methylprednisolone-loaded dendrimer nanoparticles in spinal cord injury.

  2013cited by this paper
• Functionalized Carbon Nanotubes in the Brain: Cellular Internalization and Neuroinflammatory Responses

  2013cited by this paper
• Lentiviral vectors: a powerful tool to target astrocytes in vivo.

  2013cited by this paper
• Caspase-1 activity in microglia stimulated by pro-inflammagen nanocrystals.

  2013cited by this paper
• Ultra-Sensitive Molecular MRI of Vascular Cell Adhesion Molecule-1 Reveals a Dynamic Inflammatory Penumbra After Strokes

  2013cited by this paper
• Is there a clinical future for polymeric nanoparticles as brain-targeting drug delivery agents?

  2012cited by this paper
• Multifunctionalized CMCht/PAMAM dendrimer nanoparticles modulate the cellular uptake by astrocytes and oligodendrocytes in primary cultures of glial cells.

  2012cited by this paper
• Targeting microglia-mediated neurotoxicity: the potential of NOX2 inhibitors

  2012cited by this paper
• Dendrimer-Based Postnatal Therapy for Neuroinflammation and Cerebral Palsy in a Rabbit Model

  2012cited by this paper
• Neuron-targeted copolymers with sheddable shielding blocks synthesized using a reducible, RAFT-ATRP double-head agent.

  2012influential reference
• Intracerebral CpG Immunotherapy with Carbon Nanotubes Abrogates Growth of Subcutaneous Melanomas in Mice

  2012cited by this paper
• Selective targeting of microglia by quantum dots

  2012cited by this paper
• Infiltrating Macrophages Are Key to the Development of Seizures following Virus Infection

  2012cited by this paper
• Dendrimer-Based Postnatal Therapy for Neuroinflammation and Cerebral Palsy in a Rabbit Model

  2012influential reference
• Ultra-sensitive molecular MRI of cerebrovascular cell activation enables early detection of chronic central nervous system disorders

  2012cited by this paper
• Microglia/Macrophage Polarization Dynamics Reveal Novel Mechanism of Injury Expansion After Focal Cerebral Ischemia

  2012cited by this paper
• A Dense Poly(Ethylene Glycol) Coating Improves Penetration of Large Polymeric Nanoparticles Within Brain Tissue

  2012cited by this paper
• Emerging role of Toll-like receptors in the control of pain and itch

  2012cited by this paper
• Organically Modified Silica Nanoparticles Are Biocompatible and Can Be Targeted to Neurons In Vivo

  2012cited by this paper
• Targeting Astrocytes Ameliorates Neurologic Changes in a Mouse Model of Alzheimer's Disease

  2012cited by this paper
• Drug Transport across the Blood–Brain Barrier

  2012cited by this paper
• Modulation of inflammatory signaling and cytokine release from microglia by celastrol incorporated into dendrimer nanocarriers.

  2012cited by this paper
• Macrophages as Cell-Based Delivery Systems for Nanoshells in Photothermal Therapy

  2011cited by this paper
• A phase II study of paclitaxel poliglumex (PPX), temozolamide (TMZ), and radiation (RT) for newly diagnosed high-grade gliomas.

  2011cited by this paper
• Physiology of microglia.

  2011influential reference
• The brain tumor microenvironment

  2011cited by this paper
• Pseudotype-dependent lentiviral transduction of astrocytes or neurons in the rat substantia nigra.

  2011cited by this paper
• Carbon nanotube nanoreservior for controlled release of anti-inflammatory dexamethasone.

  2011cited by this paper
• Multivalent niacin nanoconjugates for delivery to cytoplasmic lipid droplets.

  2011cited by this paper
• Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

  2011cited by this paper
• Nanoparticles enhance brain delivery of blood–brain barrier-impermeable probes for in vivo optical and magnetic resonance imaging

  2011cited by this paper
• Safety, Pharmacokinetics, and Activity of GRN1005, a Novel Conjugate of Angiopep-2, a Peptide Facilitating Brain Penetration, and Paclitaxel, in Patients with Advanced Solid Tumors

  2011cited by this paper
• NADPH oxidase is involved in post-ischemic brain inflammation.

  2011cited by this paper
• Microglia/macrophages promote glioma progression

  2011cited by this paper
• Influence of glioma tumour microenvironment on the transport of ANG1005 via low-density lipoprotein receptor-related protein 1

  2011cited by this paper
• Microglia in neurodegenerative disease

  2010cited by this paper
• Microglial ablation and lipopolysaccharide preconditioning affects pilocarpine-induced seizures in mice.

  2010cited by this paper
• New Angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) chemotherapeutics with increased brain penetration.

  2010cited by this paper
• Glioma cancer stem cells induce immunosuppressive macrophages/microglia.

  2010cited by this paper
• CX3CR1 promotes recruitment of human glioma-infiltrating microglia/macrophages (GIMs).

  2010cited by this paper
• Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132.

  2010cited by this paper
• Minocycline block copolymer micelles and their anti-inflammatory effects on microglia.

  2010cited by this paper
• In Vivo Methods to Study Uptake of Nanoparticles into the Brain

  2010cited by this paper
• Mechanisms underlying inflammation in neurodegeneration.

  2010cited by this paper

• Antibody‐Empowered Nanomedicine for Precise Biomedical Applications

  2026cites this paper
• VGF in the Nucleus Accumbens Regulates Synaptic and Opioid-Evoked Plasticity

  2025cites this paper
• Nanomaterial‐based immune therapeutic strategies in neurodegenerative diseases

  2025cites this paper
• Clinical translation of nanomedicines for brain diseases: Current challenges and future directions.

  2025cites this paper
• Exosomal MYD88 isolated from 4T1 breast cancer cells using microfluidic chips promotes depressive-like behavior through neural remodeling in the mPFC.

  2025cites this paper
• Exploring the Applications of Molecularly Imprinted Polymers in Drug Delivery to the Nervous System

  2025cites this paper
• Treating glioblastoma with dextrin-based polymers

  2025cites this paper
• Neurotrophic factors in multiple sclerosis

  2025cites this paper
• Microglia and Macrophages in Central Nervous System Homeostasis and Disease Progression: Guardians and Executioners

  2025cites this paper
• Precision targeting of the CNS: recent progress in brain-directed nanodrug delivery

  2025cites this paper
• Sustained and Step-Wise Drug Release by a Novel Double Responsive Dendrimer-N-Acetylcysteine Conjugate.

  2025cites this paper
• Framework Nucleic Acid Nanomaterials for Central Nervous System Therapies: Design for Barrier Penetration, Targeted Delivery, Cellular Uptake, and Endosomal Escape.

  2025cites this paper
• Mapping Glial Autophagy Dynamics in an Amyotrophic Lateral Sclerosis Mouse Model Reveals Microglia and Astrocyte Autophagy Dysfunction

  2025cites this paper
• Harnessing synaptic vesicle release and recycling with antibody shuttle for targeted delivery of therapeutics to neurons

  2025cites this paper
• Astrocytes and microglia in multiple sclerosis and neuromyelitis optica.

  2025cites this paper
• International Union of Basic and Clinical Pharmacology: Fundamental insights and clinical relevance regarding the carnitine palmitoyltransferase family of enzymes.

  2025cites this paper
• Nano-healing: Exploring the Therapeutic Potentials of Nanomedicine for CNS Disorders.

  2025cites this paper
• Development of a novel glucose‐dendrimer based therapeutic targeting hyperexcitable neurons in neurological disorders

  2024cites this paper
• Navigating the nano-bio immune interface: advancements and challenges in CNS nanotherapeutics

  2024cites this paper
• Nanocarrier-mediated siRNA delivery: a new approach for the treatment of traumatic brain injury–related Alzheimer’s disease

  2024cites this paper
• From Physiology to Pathology of Astrocytes: Highlighting Their Potential as Therapeutic Targets for CNS Injury

  2024cites this paper
• Journey from lab to clinic: Design, preclinical, and clinical development of systemic, targeted dendrimer-N-acetylcysteine (D-NAC) nanomedicines.

  2024cites this paper
• Polymer nanotherapeutics: A promising approach toward microglial inhibition in neurodegenerative diseases

  2024cites this paper
• Precision drug delivery to the central nervous system using engineered nanoparticles

  2024cites this paper
• Brain-targeted drug delivery - nanovesicles directed to specific brain cells by brain-targeting ligands

  2024cites this paper
• Receptor-Assisted Nanotherapeutics for Overcoming the Blood–Brain Barrier

  2024cites this paper
• Neuroglia targeting nano-therapeutic approaches to rescue aging and neurodegenerating brain.

  2024cites this paper
• Neonatal loss of FGFR2 in astroglial cells affects locomotion, sociability, working memory, and glia-neuron interactions in mice

  2023cites this paper
• Cell type-targeting nanoparticles in treating central nervous system diseases: Challenges and hopes

  2023cites this paper
• Key roles of glial cells in the encephalopathy of prematurity

  2023cites this paper
• Nanomaterial payload delivery to central nervous system glia for neural protection and repair

  2023cites this paper
• The role and potential therapeutic targets of astrocytes in central nervous system demyelinating diseases

  2023cites this paper
• Function and therapeutic value of astrocytes in diabetic cognitive impairment.

  2023cites this paper
• Integrated genomic, proteomic and cognitive assessment in Duchenne Muscular Dystrophy suggest astrocyte centric pathology

  2023cites this paper
• Cannabidiol-Loaded Nanoparticles Based on Crosslinked Starch: Anti-Inflammatory Activity and Improved Nose-to-Brain Delivery

  2023cites this paper
• Recent update on pharmacokinetics and drug metabolism in CNS-based drug discovery.

  2023cites this paper
• Engineering optical tools for remotely controlled brain stimulation and regeneration.

  2023cites this paper
• Role of Nanomedicine-Based Therapeutics in the Treatment of CNS Disorders

  2023cites this paper
• Function and therapeutic value of astrocytes in neurological diseases

  2022cites this paper
• Targeting neuroinflammation by intranasal delivery of nanoparticles in neurological diseases: a comprehensive review

  2022cites this paper
• Dendrimer-2PMPA Delays Muscle Function Loss and Denervation in a Murine Model of Amyotrophic Lateral Sclerosis

  2022cites this paper
• Targeting cell surface glycans with lectin-coated fluorescent nanodiamonds

  2022cites this paper
• Potential nanotherapeutic strategies for perioperative stroke

  2022cites this paper
• Nanoparticle delivery systems for substance use disorder

  2022cites this paper
• Effect of drug-to-lipid ratio on nanodisc-based tenofovir drug delivery to the brain for HIV-1 infection

  2022cites this paper
• Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery

  2022cites this paper
• Nanomedicines targeting the Inflammasome as a promising therapeutic approach for cell senescence.

  2022cites this paper
• Targeted Brain Delivery of Dendrimer-4-Phenylbutyrate Ameliorates Neurological Deficits in a Long-Term ABCD1-Deficient Mouse Model of X-Linked Adrenoleukodystrophy

  2022cites this paper
• CNS Delivery of Nucleic Acid Therapeutics: Beyond the Blood–Brain Barrier and Towards Specific Cellular Targeting

  2022cites this paper
• New insights into targeting mitochondria in ischemic injury

  2021cites this paper
• Targeting Microglial Disturbances to Protect the Brain From Neurodevelopmental Disorders Associated With Prematurity.

  2021cites this paper
• Therapeutic Effect of IL-4 Receptor-Targeting Pro-Apoptotic Peptide (AP1-ELP-KLAK) in Glioblastoma Tumor Model

  2021cites this paper
• Nanomaterials to target immunity.

  2021cites this paper
• Advances in the Design of (Nano)Formulations for Delivery of Antisense Oligonucleotides and Small Interfering RNA: Focus on the Central Nervous System

  2021cites this paper
• Liposome delivery to the brain with rapid short-pulses of focused ultrasound and microbubbles.

  2021cites this paper
• Nanomagnet-facilitated pharmaco-compatibility for cancer diagnostics: Underlying risks and the emergence of ultrasmall nanomagnets

  2021cites this paper
• Targeted drug delivery systems to control neuroinflammation in central nervous system disorders

  2021cites this paper
• Neuroinflammation Treatment via Targeted Delivery of Nanoparticles

  2020cites this paper
• Microglia-targeting nanotherapeutics for neurodegenerative diseases

  2020cites this paper
• A dual mode nanophotonics concept for in situ activation of brain immune cells using a photoswitchable yolk-shell upconversion nanoformulation.

  2020cites this paper
• An overview of nanomedicines for neuron targeting.

  2020cites this paper
• An Elvitegravir Nanoformulation Crosses the Blood–Brain Barrier and Suppresses HIV-1 Replication in Microglia

  2020cites this paper
• Modeling Controlled Cortical Impact Injury in 3D Brain‐Like Tissue Cultures

  2020cites this paper
• In Vivo Antidepressant Effect of Passiflora edulis f. flavicarpa into Cationic Nanoparticles: Improving Bioactivity and Safety

  2020influential citation
• ORALLY ADMINISTERED NANOTHERAPEUTICS FOR PARKINSON DISEASE: AN OLD DELIVERY SYSTEM YET MORE ACCEPTABLE.

  2020cites this paper
• RNA Delivery via DNA-Inspired Janus Base Nanotubes for Extracellular Matrix Penetration

  2020cites this paper
• Cellular Specificity and Inter-cellular Coordination in the Brain Bioenergetic System: Implications for Aging and Neurodegeneration

  2020cites this paper
• Breaking Barriers: Bioinspired Strategies for Targeted Neuronal Delivery to the Central Nervous System

  2020cites this paper
• Chemo-physical Strategies to Advance the in Vivo Functionality of Targeted Nanomedicine: The Next Generation.

  2020cites this paper
• Autophagy in Multiple Sclerosis: Two Sides of the Same Coin

  2020cites this paper
• A Novel Elvitegravir Nanoformulation for Drug Delivery Across the Blood-Brain Barrier to Suppress HIV-1 in Macrophages and Microglia

  2020cites this paper
• Toward the therapeutic application of small interfering RNA bioconjugates in the central nervous system

  2020cites this paper
• Systemic dendrimer-drug nanomedicines for long-term treatment of mild-moderate cerebral palsy in a rabbit model

  2020cites this paper
• Liposomes vs Phytosomes: Principles, Methodologies, and Therapeutic Applications with Emphasis on CNS Disorders

  2020cites this paper
• Nanoparticle‐microglial interaction in the ischemic brain is modulated by injury duration and treatment

  2020cites this paper
• Seizure initiation in infantile spasms vs. focal seizures: proposed common cellular mechanisms

  2019cites this paper
• Neuronanotechnology for brain regeneration.

  2019cites this paper
• Selective Modulation of A1 Astrocytes by Drug-Loaded Nano-Structured Gel in Spinal Cord Injury.

  2019cites this paper
• How can nanovectors be used to treat spinal cord injury?

  2019cites this paper
• Nanovector-Mediated Drug Delivery in Spinal Cord Injury: A Multitarget Approach.

  2019cites this paper
• Impact of Curcuma longa extract on the expression level of brain transporters in in vivo model

  2019influential citation
• Therapeutic nanoplatforms and delivery strategies for neurological disorders

  2018cites this paper
• Microglia in the Retina: Roles in Development, Maturity, and Disease.

  2018cites this paper
• Doxorubicin and indocyanine green loaded superparamagnetic iron oxide nanoparticles with PEGylated phospholipid coating for magnetic resonance with fluorescence imaging and chemotherapy of glioma

  2018cites this paper
• Effect of mannose targeting of hydroxyl PAMAM dendrimers on cellular and organ biodistribution in a neonatal brain injury model

  2018cites this paper
• Use of Polyamidoamine Dendrimers in Brain Diseases

  2018cites this paper
• Concepts toward directing human astroplasticity to promote neuroregeneration

  2018cites this paper
• Envisioning the future of polymer therapeutics for brain disorders.

  2018cites this paper
• Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases.

  2017cites this paper
• Lipoprotein-biomimetic nanostructure enables efficient targeting delivery of siRNA to Ras-activated glioblastoma cells via macropinocytosis

  2017cites this paper
• Generation‐6 hydroxyl PAMAM dendrimers improve CNS penetration from intravenous administration in a large animal brain injury model

  2017cites this paper
• Uptake of dendrimer-drug by different cell types in the hippocampus after hypoxic-ischemic insult in neonatal mice: Effects of injury, microglial activation and hypothermia.

  2017cites this paper
• Advances in Targeted Drug Delivery Approaches for the Central Nervous System Tumors: The Inspiration of Nanobiotechnology

  2016cites this paper
• Surface functionality affects the biodistribution and microglia-targeting of intra-amniotically delivered dendrimers.

  2016cites this paper
• Nanoscale effects in dendrimer-mediated targeting of neuroinflammation.

  2016cites this paper
• The Open Repository @ Binghamton (The ORB) The Open Repository @ Binghamton (The ORB)

  year unknowncites this paper